论文部分内容阅读
目的比较我国各种抗青光眼滴眼液的每日费用。设计调查研究。研究对象我国市场上主要的抗青光眼滴眼液 15种。方法选取我国市场上主要的抗青光眼滴眼液16种,每种滴眼液5瓶,分别由5名研究者记录单瓶滴数,计算平均单瓶滴数、单滴药物容量、单瓶滴眼液双眼使用天数和每日费用。主要指标每种滴跟液单瓶双眼使用天数及每日费用。结果抗青光眼滴眼液的单滴药物容量为0.027ml(卢美根)-0.053ml(诚瑞和0.5%真瑞);单瓶价格从5.7元(马来酸噻吗洛尔)到338元(适利达)不等;单瓶滴眼液双眼使用天数从12天(真瑞)到52天(卢美根)。抗青光眼滴眼液双眼同时应用时的每日费用为:适利达 7.51元、苏为坦6.30元、卢美根3.84元、阿法根3.36元、迪立见2.97元、派立明2.83元、2%真瑞2.34元、贝他根2.11元、贝特舒 2.0元、0.5%真瑞1.49元、2%护明1.29元、1%和2%美开朗1.21元、1%护明0.85元、诚瑞0.63元、马来酸噻吗洛尔0.23元。结论我国市场上的抗青光眼滴眼液治疗费用高低悬殊。本研究结果的数据可能对我国青光眼药物治疗费用的预算和选择有参考价值。
Objective To compare the daily cost of various anti-glaucoma eye drops in China. Design survey research. Research object 15 major anti-glaucoma eye drops on the Chinese market. Methods Sixteen kinds of anti-glaucoma eye drops, five bottles for each eye drop, were selected on the market in our country. Five single-bottle drops were recorded by each researcher, and the average single bottle drip number, single drop drug volume, single bottle drop Eyelid eyes use the number of days and daily costs. The main indicators of each drop with a single bottle of both eyes use the number of days and the daily cost. Results Anti-glaucoma eye drops single-drug capacity 0.027ml (Lumex root) -0.053ml (Cheng Rui and 0.5% Zhenrui); single bottle price from 5.7 yuan (timolol maleate ) To 338 yuan (Qi Li Da) ranging from single-eye drops eyes use days from 12 days (true Swiss) to 52 days (Lumex root). Anti-glaucoma eye drops, while the daily cost of both eyes when applied: 7.51 yuan for the benefit, Su for Tanzania 6.30 yuan, 3.68 yuan Lu Mei root, 3.36 yuan 阿法根, Di see 2.97 yuan , Perming 2.83 yuan, 2% true Swiss 2.34 yuan, Beta- geng 2.11 yuan, Berthe 2.0 yuan, 0.5% true Swiss 1.49 yuan, 2% Huiming 1 .29 yuan, 1% and 2% of the United States cheerful 1.21 yuan, 1% care of 0.85 yuan, Cheng Rui 0.63 yuan, timolol maleate 0.23 yuan. Conclusion Our country market anti-glaucoma eye drops treatment costs disparity. The data of the results of this study may have reference value for the budget and choice of the cost of treating glaucoma in our country.